Researcher
Kathelijne Peerlinck
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 30 Sep 2021
Projects
1 - 4 of 4
- Genome medicine for bleeding, thrombotic and platelet disordersFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
- Quantification of joint loading in adults with haemophilia using multi-segment foot modellingFrom1 Mar 2018 → 8 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Biomechanische determinanten en patronen geassocieerd aan de pathophysiologische enkelarthropathie cascade van kinderen met haemophilie.From1 Oct 2014 → 30 Sep 2016Funding: BOF - Other initiatives
- (Epi)Genetic studies and system biology approaches to characterize rare inherited bleeding and platelet disorders: from patient studies to basic biology to cl inical applicationsFrom1 Oct 2014 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
Publications
21 - 30 of 108
- Blood-induced cartilage damage alters the ankle joint load during walking(2020)
Authors: Maarten Eerdekens, Kathelijne Peerlinck, Filip Staes, Lennart Scheys, Kevin Deschamps
Pages: 2419 - 2428 - The biomechanical behaviour of ankle and foot joints during walking with shoes in patients with haemophilia(2020)
Authors: Maarten Eerdekens, Kathelijne Peerlinck, Filip Staes, Kevin Deschamps
Pages: 726 - 734 - Anticoagulant therapy in COVID-19 critically ill: Should we go for more?(2020)
Authors: Christophe Vandenbriele, Lucas Van Aelst, Dieter Dauwe, Marion Delcroix, Jan Gunst, Marc Jacquemin, Kathelijne Peerlinck, Thomas Vanassche, Joost Wauters, Alexander Wilmer, et al.
Pages: 156 - 158 - Eliminating viral hepatitis C in Belgium: the micro-elimination approach(2020)
Authors: Frederik Nevens, Kathelijne Peerlinck
- Clinical gait features are associated with MRI findings in patients with haemophilic ankle arthropathy(2020)
Authors: Maarten Eerdekens, Kathelijne Peerlinck, Filip Staes, Kevin Deschamps
Pages: 333 - 339 - Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience(2019)
Authors: Kathelijne Peerlinck, Frederik Nevens
Pages: 1028 - 1034 - THE NATURAL HISTORY OF NONSEVERE HEMOPHILIA A: WHAT IS THE EXPECTED TIMING OF THE INITIAL EX POSURES TO FACTOR VIII TREATMENT?(2019)
Authors: Kathelijne Peerlinck
Pages: 10 - 10 - The concentration of GPIbα magnetic particles is a critical parameter occasionally responsible for poor reproducibility of the VWF:GPIbR chemiluminescent immunoassay(2019)
Authors: Bas Calcoen, Kathelijne Peerlinck, Marc Jacquemin
Pages: e79 - e80 - Quantifying clinical misinterpretations associated to one-segment kinetic foot modelling in both a healthy and patient population(2019)
Authors: Maarten Eerdekens, Filip Staes, Giovanni Matricali, Sander Wuite, Kathelijne Peerlinck, Kevin Deschamps
Pages: 160 - 165 - Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study(2019)
Authors: Kathelijne Peerlinck
Pages: E295 - E305